Cargando…

Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein Activation

OBJECTIVE: The iboga alkaloids are a class of small molecules defined structurally on the basis of a common ibogamine skeleton, some of which modify opioid withdrawal and drug self-administration in humans and preclinical models. These compounds may represent an innovative approach to neurobiologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antonio, Tamara, Childers, Steven R., Rothman, Richard B., Dersch, Christina M., King, Christine, Kuehne, Martin, Bornmann, William G., Eshleman, Amy J., Janowsky, Aaron, Simon, Eric R., Reith, Maarten E. A., Alper, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818563/ https://www.ncbi.nlm.nih.gov/pubmed/24204784 http://dx.doi.org/10.1371/journal.pone.0077262

Ejemplares similares

Structural Basis of Cycloaddition in Biosynthesis of Iboga and Aspidosperma Alkaloids
por: Caputi, Lorenzo, et al.
Publicado: (2020)

New Iboga-Type Indole Alkaloids from Tabernaemontana divaricata
por: Li, Xiang-Mei, et al.
Publicado: (2019)

Enantioselective synthesis of Iboga alkaloids and vinblastine via rearrangements of quaternary ammoniums
por: Zhang, Yun, et al.
Publicado: (2016)

Biosynthesis of an Anti-Addiction Agent from the Iboga Plant
por: Farrow, Scott C., et al.
Publicado: (2019)

Solution of the multistep pathway for assembly of corynanthean, strychnos, iboga, and aspidosperma monoterpenoid indole alkaloids from 19E-geissoschizine
por: Qu, Yang, et al.
Publicado: (2018)

Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga
por: Farrow, Scott C., et al.
Publicado: (2018)

Two Novel Iboga-Type and an Oxindole Glucuronide Alkaloid from Tabernaemontana peduncularis Disclose Related Biosynthetic Pathways to Tabernaemontana divaricata
por: Traxler, Florian, et al.
Publicado: (2023)

Efficient Access to the Iboga Skeleton: Optimized Procedure to Obtain Voacangine from Voacanga africana Root Bark
por: González, Bruno, et al.
Publicado: (2021)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Iboga Inspired N-Indolylethyl-Substituted Isoquinuclidines as a Bioactive Scaffold: Chemoenzymatic Synthesis and Characterization as GDNF Releasers and Antitrypanosoma Agents
por: Pazos, Mariana, et al.
Publicado: (2022)

Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function
por: Shi, Xiao, et al.
Publicado: (2016)

Quantitative Detection of µ Opioid Receptor: Western Blot Analyses Using µ Opioid Receptor Knockout Mice
por: Kasai, Shinya, et al.
Publicado: (2011)

Palmitoylation and membrane cholesterol stabilize μ-opioid receptor homodimerization and G protein coupling
por: Zheng, Hui, et al.
Publicado: (2012)

Opioid peptides and opiate alkaloids in immunoregulatory processes
por: Stefano, George B., et al.
Publicado: (2010)

How μ-Opioid Receptor Recognizes Fentanyl
por: Vo, Quynh N., et al.
Publicado: (2020)

How μ-Opioid Receptor Recognizes Fentanyl
por: Vo, Quynh N., et al.
Publicado: (2020)

How μ-opioid receptor recognizes fentanyl
por: Vo, Quynh N., et al.
Publicado: (2021)

Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor
por: Perez-Aguilar, Jose Manuel, et al.
Publicado: (2012)

Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists
por: Ma, Mengjun, et al.
Publicado: (2019)

Structural insights into μ-opioid receptor activation
por: Huang, Weijiao, et al.
Publicado: (2015)

A highly D(3)R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D(3)R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder
por: Galaj, Ewa, et al.
Publicado: (2022)

Cellular tolerance at the µ-opioid receptor is phosphorylation dependent
por: Arttamangkul, Seksiri, et al.
Publicado: (2018)

μ-Opioid receptor activation modulates CA3-to-CA1 gamma oscillation phase-coupling
por: Zhang, Yujiao, et al.
Publicado: (2019)

Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction
por: Sadee, Wolfgang, et al.
Publicado: (2022)

Pharmacological Profiles of Oligomerized μ-Opioid Receptors
por: Lee, Cynthia Wei-Sheng, et al.
Publicado: (2013)

μ-Opioid receptor desensitization: homologous or heterologous?
por: Llorente, Javier, et al.
Publicado: (2012)

Neuropsychological Functions of μ- and δ-Opioid Systems
por: Polunina, Anna G., et al.
Publicado: (2013)

Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
por: Yang, Yin, et al.
Publicado: (2018)

Kinetics and Mechanism of Fentanyl Dissociation from the μ-Opioid Receptor
por: Mahinthichaichan, Paween, et al.
Publicado: (2021)

Clinical opioids differentially induce co-internalization of μ- and δ-opioid receptors
por: Bao, Fenghua, et al.
Publicado: (2018)

Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism
por: Giuliano, Chiara, et al.
Publicado: (2013)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
por: Moynihan, Humphrey A., et al.
Publicado: (2012)

Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands
por: Harland, Aubrie A., et al.
Publicado: (2016)

Structure of the μ Opioid Receptor-G(i) Protein Complex
por: Koehl, Antoine, et al.
Publicado: (2018)

Response of the μ-opioid system to social rejection and acceptance
por: Hsu, David T, et al.
Publicado: (2013)

μ Opioid receptor: novel antagonists and structural modeling
por: Kaserer, Teresa, et al.
Publicado: (2016)

State-dependent μ-opioid modulation of social motivation
por: Loseth, Guro E., et al.
Publicado: (2014)

Methylnaltrexone: Peripherally Acting µ-Opioid Receptor Antagonist
por: Uritsky, Tanya J.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ka1vli9s348df6p8htp550fs7a